Micro Cap Growth Fund
Daily price w/o sales charge as of 03/10/2026
$19.81
$0.10
YTD Returns w/o sales charge as of 03/10/2026
1.64%
Overall Morningstar RatingsSmall Growth
as of 02/28/2026
Morningstar rated the Lord Abbett Micro Cap Growth Fund class A share 3, 2 and 5 stars among 519, 497 and 394 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 2/28/2026, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 02/27/2026
- Total Net Assets
- $187.73 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.37%
- Fund Net Expense Ratio
- 1.37%
- Number of Holdings
- 79
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 3.95% | 26.07% | 12.66% | -0.87% | 17.36% | 10.39% |
| Lipper Category Avg. Small-Cap Growth Funds | 4.34% | 16.82% | 11.88% | 1.98% | 11.90% | - |
| Russell Microcap® Growth Index | 2.75% | 35.22% | 15.88% | -0.44% | 9.87% | - |
| w/ sales charge | -2.03% | 18.83% | 10.47% | -2.04% | 16.66% | 10.14% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 10.74% | 10.74% | 14.16% | 1.72% | 14.33% | 10.29% |
| Lipper Category Avg. Small-Cap Growth Funds | 8.15% | 8.15% | 13.21% | 2.52% | 10.17% | - |
| Russell Microcap® Growth Index | 21.84% | 21.84% | 17.46% | 2.81% | 7.82% | - |
| w/ sales charge | 4.39% | 4.39% | 11.93% | 0.52% | 13.66% | 10.04% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 01/30/2026View Portfolio
| Holding | Assets |
|---|---|
| Cogent Biosciences Inc | 3.6% |
| Adaptive Biotechnologies Corp | 3.3% |
| Celcuity Inc | 2.9% |
| Applied Digital Corp | 2.9% |
| Willdan Group Inc | 2.7% |
| Mirum Pharmaceuticals Inc | 2.7% |
| Tarsus Pharmaceuticals Inc | 2.4% |
| Centrus Energy Corp | 2.2% |
| Terns Pharmaceuticals Inc | 2.2% |
| Terawulf Inc | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 02/27/2026View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 3.95% | 26.07% | 12.66% | -0.87% | 17.36% | 10.39% |
| Lipper Category Avg. Small-Cap Growth Funds | 4.34% | 16.82% | 11.88% | 1.98% | 11.90% | - |
| Russell Microcap® Growth Index | 2.75% | 35.22% | 15.88% | -0.44% | 9.87% | - |
| w/ sales charge | -2.03% | 18.83% | 10.47% | -2.04% | 16.66% | 10.14% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 10.74% | 10.74% | 14.16% | 1.72% | 14.33% | 10.29% |
| Lipper Category Avg. Small-Cap Growth Funds | 8.15% | 8.15% | 13.21% | 2.52% | 10.17% | - |
| Russell Microcap® Growth Index | 21.84% | 21.84% | 17.46% | 2.81% | 7.82% | - |
| w/ sales charge | 4.39% | 4.39% | 11.93% | 0.52% | 13.66% | 10.04% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2025 | 10.74% | 21.84% |
| 2024 | 26.89% | 21.91% |
| 2023 | 5.88% | 9.11% |
| 2022 | -29.27% | -29.76% |
| 2021 | 3.46% | 0.88% |
| 2020 | 79.42% | 40.13% |
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | - |
| 2014 | 10.83% | - |
| 2013 | 78.53% | - |
| 2012 | 2.35% | - |
| 2011 | -5.87% | - |
| 2010 | 33.77% | - |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2026 | - | - | - | - |
| 2025 | -17.90% | 15.85% | 13.92% | 2.20% |
| 2024 | 7.64% | 0.07% | 6.89% | 10.21% |
| 2023 | 5.50% | 4.20% | -13.40% | 11.23% |
| 2022 | -17.22% | -22.57% | 8.17% | 2.02% |
| 2021 | 12.29% | -0.15% | -9.42% | 1.87% |
| 2020 | -24.28% | 47.61% | 17.48% | 36.65% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 02/28/2026
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Cogent Biosciences Inc | Health Care | 3.6% |
| Adaptive Biotechnologies Corp | Health Care | 3.3% |
| Celcuity Inc | Health Care | 2.9% |
| Applied Digital Corp | Information Technology | 2.9% |
| Willdan Group Inc | Industrials | 2.7% |
| Mirum Pharmaceuticals Inc | Health Care | 2.7% |
| Tarsus Pharmaceuticals Inc | Health Care | 2.4% |
| Centrus Energy Corp | Energy | 2.2% |
| Terns Pharmaceuticals Inc | Health Care | 2.2% |
| Terawulf Inc | Information Technology | 2.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Cogent Biosciences Inc | Health Care | 3.6% |
| Adaptive Biotechnologies Corp | Health Care | 3.3% |
| Celcuity Inc | Health Care | 2.9% |
| Applied Digital Corp | Information Technology | 2.9% |
| Willdan Group Inc | Industrials | 2.7% |
| Mirum Pharmaceuticals Inc | Health Care | 2.7% |
| Tarsus Pharmaceuticals Inc | Health Care | 2.4% |
| Centrus Energy Corp | Energy | 2.2% |
| Terns Pharmaceuticals Inc | Health Care | 2.2% |
| Terawulf Inc | Information Technology | 2.2% |
| Mercury Systems Inc | Industrials | 2.1% |
| Artivion Inc | Health Care | 2.1% |
| TAT Technologies Ltd | Industrials | 2.0% |
| CECO Environmental Corp | Industrials | 2.0% |
| Primoris Services Corp | Industrials | 2.0% |
| Xometry Inc | Industrials | 2.0% |
| VSE Corp | Industrials | 1.9% |
| Bel Fuse Inc | Information Technology | 1.8% |
| Sterling Infrastructure Inc | Industrials | 1.8% |
| PTC Therapeutics Inc | Health Care | 1.8% |
| Vita Coco Co Inc/The | Consumer Staples | 1.7% |
| OSI Systems Inc | Information Technology | 1.6% |
| Pattern Group Inc | Consumer Discretionary | 1.6% |
| nLight Inc | Information Technology | 1.5% |
| Piper Sandler Cos | Financials | 1.5% |
| Praxis Precision Medicines Inc | Health Care | 1.4% |
| Cardinal Infrastructure Group Inc | Industrials | 1.4% |
| Calix Inc | Information Technology | 1.4% |
| Mineralys Therapeutics Inc | Health Care | 1.4% |
| Standex International Corp | Industrials | 1.4% |
| Lindblad Expeditions Holdings Inc | Consumer Discretionary | 1.4% |
| Huron Consulting Group Inc | Industrials | 1.3% |
| Paymentus Holdings Inc | Financials | 1.3% |
| CG oncology Inc | Health Care | 1.3% |
| Universal Technical Institute Inc | Consumer Discretionary | 1.2% |
| Lincoln Educational Services Corp | Consumer Discretionary | 1.2% |
| Legence Corp | Industrials | 1.1% |
| Gilat Satellite Networks Ltd | Information Technology | 1.1% |
| BlackSky Technology Inc | Industrials | 1.1% |
| Sphere Entertainment Co | Communication Services | 1.1% |
| Miami International Holdings Inc | Financials | 1.0% |
| Arcellx Inc | Health Care | 1.0% |
| Rhythm Pharmaceuticals Inc | Health Care | 1.0% |
| GeneDx Holdings Corp | Health Care | 1.0% |
| TransMedics Group Inc | Health Care | 1.0% |
| Ouster Inc | Information Technology | 1.0% |
| Agilysys Inc | Information Technology | 1.0% |
| HeartFlow Inc | Health Care | 0.9% |
| Dave Inc | Financials | 0.9% |
| IMAX Corp | Communication Services | 0.9% |
| Innodata Inc | Industrials | 0.9% |
| AAR Corp | Industrials | 0.9% |
| ORIC Pharmaceuticals Inc | Health Care | 0.8% |
| Dianthus Therapeutics Inc | Health Care | 0.8% |
| Ambarella Inc | Information Technology | 0.7% |
| Kestra Medical Technologies Ltd | Health Care | 0.7% |
| Arlo Technologies Inc | Information Technology | 0.7% |
| Red Violet Inc | Information Technology | 0.7% |
| Newamsterdam Pharma Co NV | Health Care | 0.7% |
| Powell Industries Inc | Industrials | 0.6% |
| Billiontoone Inc | Health Care | 0.6% |
| ThredUp Inc | Consumer Discretionary | 0.6% |
| Aehr Test Systems | Information Technology | 0.6% |
| Argan Inc | Industrials | 0.6% |
| Chefs' Warehouse Inc/The | Consumer Staples | 0.5% |
| Turning Point Brands Inc | Consumer Staples | 0.5% |
| Omada Health Inc | Health Care | 0.5% |
| Immunocore Holdings PLC | Health Care | 0.5% |
| Ceribell Inc | Health Care | 0.5% |
| Warby Parker Inc | Consumer Discretionary | 0.5% |
| Hinge Health Inc | Health Care | 0.5% |
| Neptune Insurance Holdings Inc | Financials | 0.4% |
| Zeta Global Holdings Corp | Information Technology | 0.4% |
| Grid Dynamics Holdings Inc | Information Technology | 0.4% |
| Beta Bionics Inc | Health Care | 0.2% |
| Black Rock Coffee Bar Inc | Consumer Discretionary | 0.2% |
| Forte Biosciences Inc | Health Care | 0.1% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 02/27/2026
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
1.2%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
1.7%
|
|
| Consumer Staples |
1.5%
|
|
| Energy |
 1.5%
|
|
| Financials |
1.2%
|
|
| Health Care |
2.8%
|
|
| Industrials |
1.1%
|
|
| Information Technology |
0.8%
|
|
| Materials | 0.0% |
Portfolio Details as of 02/27/2026
- Total Net Assets
- $187.73 M
- Number of Holdings
- 79
- Weighted Average Market Cap.
- 3.8 B
- P/B Ratio
- 6.4x
- P/E Ratio
- 37.1x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 03/10/2026
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2026 | 11/24/2026 | 11/24/2026 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 03/10/2026
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $21.02 |
| $50,000 to $99,999 | 4.75% | 4.00% | $20.80 |
| $100,000 to $249,999 | 3.95% | 3.25% | $20.62 |
| $250,000 to $499,999 | 2.75% | 2.25% | $20.37 |
| $500,000 to $999,999 | 1.95% | 1.75% | $20.20 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $19.81 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 02/28/2026
| Fund Gross Expense Ratio | 1.37% |
| Fund Net Expense Ratio | 1.37% |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
2025 Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
2025 Semi-Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|